If you or a loved one developed a blood clot due to the drug Xeljanz, you may be eligible to file a lawsuit against the manufacturer. It is known to increase the risk of heart failure, pulmonary embolism, and cancer. Many people who take this drug have also developed cardiovascular problems, including heart attacks and strokes. Currently, Xeljanz lawsuits are being accepted from people who have experienced blood clots in the legs, lungs, or other locations.
To take the medication, you must follow all instructions on the label. The XELJANZ Oral Solution should be taken within 60 days of opening. After this time, the solution should be disposed of. Always read the instructions for use and keep the bottle out of reach of children. If you are using XELJANZ as directed by your healthcare provider, follow the directions on the label and read the XELJANZ Oral Solution product leaflet carefully.
In February 2021, the FDA released a Drug Safety Communication (DSC) alerting the public of an increased risk of heart attacks and other cardiovascular events, including stroke. In addition, Xeljanz may increase the risk of cancer and lymphoma. The FDA has no way to verify the data reported by patients and doctors, so it is likely that more cases are occurring than those reported. Nonetheless, Xeljanz lawsuits can help patients fight the drug company.
The FDA approved Xeljanz lawyer for bacterial, viral, and opportunistic infections. However, there is a risk of developing tuberculosis in patients who take the medication. Therefore, it is critical for patients to undergo a medical test to rule out a diagnosis of tuberculosis before starting XELJANZ. It is essential to monitor patients closely and seek medical attention as soon as symptoms appear.
No comments:
Post a Comment